Experienced in Cherry Angioma

Dr. Jennifer Parish

Dermatology
Office
1845 Walnut St Ste 1650, 
Philadelphia, PA 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Cherry Angioma
Office
1845 Walnut St Ste 1650, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jennifer Parish is a Dermatologist in Philadelphia, Pennsylvania. Dr. Parish is rated as an Experienced provider by MediFind in the treatment of Cherry Angioma. Her top areas of expertise are Jock Itch, Athlete's Foot, Perioral Dermatitis, and Sunburn.

Her clinical research consists of co-authoring 24 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Dermatology
Licenses
Dermatology in PA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Office
1845 Walnut St Ste 1650, Philadelphia, PA 19103

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Single Treatment Pharmacokinetic and Safety Study of Natroba (Spinosad) Topical Suspension 0.9% w/w in Subjects 1 Month to 3 Years 11 Months of Age With an Active Scabies Infestation
A Single Treatment Pharmacokinetic and Safety Study of Natroba (Spinosad) Topical Suspension 0.9% w/w in Subjects 1 Month to 3 Years 11 Months of Age With an Active Scabies Infestation
Enrollment Status: Recruiting
Publish Date: February 14, 2025
Intervention Type: Drug
Study Phase: Phase 4
Phase 2a Prospective, Randomized, Double-blind, Intra-subject, Placebo-controlled, Proof of Concept Study to Evaluate the Efficacy of OLX10010 as an Adjunct Therapy to Reduce the Recurrence of Hypertrophic Scars After Scar Revision Surgery
Phase 2a Prospective, Randomized, Double-blind, Intra-subject, Placebo-controlled, Proof of Concept Study to Evaluate the Efficacy of OLX10010 as an Adjunct Therapy to Reduce the Recurrence of Hypertrophic Scars After Scar Revision Surgery
Enrollment Status: Completed
Publish Date: February 21, 2024
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate Efficacy, Pharmacokinetics, and Safety of Multiple Intravenous Doses of FB825 in Adults With Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate Efficacy, Pharmacokinetics, and Safety of Multiple Intravenous Doses of FB825 in Adults With Atopic Dermatitis
Enrollment Status: Unknown
Publish Date: April 04, 2022
Intervention Type: Biological, Other
Study Drug: FB825
Study Phase: Phase 2
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneously Delivered ASLAN004 in Adults With Moderate-Severe Atopic Dermatitis
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneously Delivered ASLAN004 in Adults With Moderate-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: January 12, 2022
Intervention Type: Drug
Study Drug: ASLAN004
Study Phase: Phase 1
Open-Label Study of the Pharmacokinetics and Safety Including HPA Axis Suppression Potential of Clobetasol Topical Oil in Pediatric Subjects With Moderate to Severe Atopic Dermatitis
Open-Label Study of the Pharmacokinetics and Safety Including HPA Axis Suppression Potential of Clobetasol Topical Oil in Pediatric Subjects With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: June 23, 2021
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Phase 3, Randomized, Double Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Natroba™ (Spinosad) for the Treatment of Scabies
A Phase 3, Randomized, Double Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Natroba™ (Spinosad) for the Treatment of Scabies
Enrollment Status: Completed
Publish Date: May 21, 2021
Intervention Type: Other, Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

24 Total Publications

Safety and Efficacy of LP-10 Liposomal Tacrolimus in Oral Lichen Planus: A Multicenter Phase 2 Trial.
Safety and Efficacy of LP-10 Liposomal Tacrolimus in Oral Lichen Planus: A Multicenter Phase 2 Trial.
Journal: Dermatology and therapy
Published: September 22, 2025
Similar Doctors
Distinguished in Cherry Angioma
Dr. Joseph Hong
Dermatology
Distinguished in Cherry Angioma
Dr. Joseph Hong
Dermatology

Office

1401 New Rd Ste A, 
Linwood, NJ 
 (52.7 miles away)
609-927-5885
Languages Spoken:
English
See accepted insurances

Joseph Hong is a Dermatologist in Linwood, New Jersey. Dr. Hong is rated as a Distinguished provider by MediFind in the treatment of Cherry Angioma. His top areas of expertise are Kaposiform Hemangioendothelioma, Hemangioma, Cerebral Cavernous Malformation, and Hemangioendothelioma.

Distinguished in Cherry Angioma
Dr. Daniel Shurman
Dermatology
Distinguished in Cherry Angioma
Dr. Daniel Shurman
Dermatology

Office

258 Ben Franklin Hwy E, 
Birdsboro, PA 
 (39.2 miles away)
610-288-2908
Languages Spoken:
English
See accepted insurances

Daniel Shurman is a Dermatologist in Birdsboro, Pennsylvania. Dr. Shurman is rated as a Distinguished provider by MediFind in the treatment of Cherry Angioma. His top areas of expertise are Rosacea, Sunburn, Warts, and Actinic Keratosis.

Distinguished in Cherry Angioma
Dr. Elana Segal
Dermatology
Distinguished in Cherry Angioma
Dr. Elana Segal
Dermatology

Dermatology Center Of Washington Township PC

100 Kings Way E Ste A3, 
Sewell, NJ 
 (16.1 miles away)
856-589-3331
Languages Spoken:
English
See accepted insurances

Elana Segal is a Dermatologist in Sewell, New Jersey. Dr. Segal is rated as a Distinguished provider by MediFind in the treatment of Cherry Angioma. Her top areas of expertise are Universal Acquired Melanosis, Liver Spots, Kaposiform Hemangioendothelioma, and Fetal Cystic Hygroma.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Parish's expertise for a condition
ConditionClose
    View All 16 Advanced Conditions
    View All 43 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile